250 related articles for article (PubMed ID: 27147504)
1. Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells.
Reinhard NR; van Helden SF; Anthony EC; Yin T; Wu YI; Goedhart J; Gadella TW; Hordijk PL
Sci Rep; 2016 May; 6():25502. PubMed ID: 27147504
[TBL] [Abstract][Full Text] [Related]
2. RhoA, RhoB and RhoC differentially regulate endothelial barrier function.
Pronk MCA; van Bezu JSM; van Nieuw Amerongen GP; van Hinsbergh VWM; Hordijk PL
Small GTPases; 2019 Nov; 10(6):466-484. PubMed ID: 28949796
[TBL] [Abstract][Full Text] [Related]
3. Endothelial RhoB and RhoC are dispensable for leukocyte diapedesis and for maintaining vascular integrity during diapedesis.
Schimmel L; de Ligt A; Tol S; de Waard V; van Buul JD
Small GTPases; 2020 May; 11(3):225-232. PubMed ID: 28960175
[TBL] [Abstract][Full Text] [Related]
4. A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology.
Eckenstaler R; Hauke M; Benndorf RA
Biochem Pharmacol; 2022 Dec; 206():115321. PubMed ID: 36306821
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.
Nomikou E; Livitsanou M; Stournaras C; Kardassis D
Cell Mol Life Sci; 2018 Jun; 75(12):2111-2124. PubMed ID: 29500478
[TBL] [Abstract][Full Text] [Related]
6. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
7. The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.
Tseliou M; Al-Qahtani A; Alarifi S; Alkahtani SH; Stournaras C; Sourvinos G
Cell Physiol Biochem; 2016; 38(1):94-109. PubMed ID: 26741994
[TBL] [Abstract][Full Text] [Related]
8. Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB.
García-Mariscal A; Li H; Pedersen E; Peyrollier K; Ryan KM; Stanley A; Quondamatteo F; Brakebusch C
Oncogene; 2018 Feb; 37(7):847-860. PubMed ID: 29059167
[TBL] [Abstract][Full Text] [Related]
9. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
10. Divergence of Rho residue 43 impacts GEF activity.
Sloan CM; Quinn CV; Peters JP; Farley J; Goetzinger C; Wernli M; DeMali KA; Ellerbroek SM
Small GTPases; 2012; 3(1):15-22. PubMed ID: 22673745
[TBL] [Abstract][Full Text] [Related]
11. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.
Wheeler AP; Ridley AJ
Exp Cell Res; 2004 Nov; 301(1):43-9. PubMed ID: 15501444
[TBL] [Abstract][Full Text] [Related]
12. Toward Novel Diagnostics for Primary Open-Angle Glaucoma? An Association Study of Polymorphic Variation in Ras Homolog Family Member (A, B, C, D) Genes RHOA, RHOB, RHOC, and RHOD.
Saracaloglu A; Demiryürek S; Okumus S; Oztuzcu S; Bozgeyik I; Coskun E; Aksoy U; Kaydu E; Erbagci I; Gürler B; Alasehirli B; Demiryürek AT
OMICS; 2016 May; 20(5):290-5. PubMed ID: 27195967
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-induced ArhGEF10 selectively activates RhoB contributing to human microvascular endothelial cell tight junction disruption.
Khan A; Ni W; Lopez-Giraldez F; Kluger MS; Pober JS; Pierce RW
FASEB J; 2021 Jun; 35(6):e21627. PubMed ID: 33948992
[TBL] [Abstract][Full Text] [Related]
14. Differential binding of RhoA, RhoB, and RhoC to protein kinase C-related kinase (PRK) isoforms PRK1, PRK2, and PRK3: PRKs have the highest affinity for RhoB.
Hutchinson CL; Lowe PN; McLaughlin SH; Mott HR; Owen D
Biochemistry; 2013 Nov; 52(45):7999-8011. PubMed ID: 24128008
[TBL] [Abstract][Full Text] [Related]
15. p120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by impairing Src dependent VE-cadherin phosphorylation.
Alcaide P; Martinelli R; Newton G; Williams MR; Adam A; Vincent PA; Luscinskas FW
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C385-95. PubMed ID: 22648953
[TBL] [Abstract][Full Text] [Related]
16. RhoA-GDP regulates RhoB protein stability. Potential involvement of RhoGDIalpha.
Ho TT; Merajver SD; Lapière CM; Nusgens BV; Deroanne CF
J Biol Chem; 2008 Aug; 283(31):21588-98. PubMed ID: 18524772
[TBL] [Abstract][Full Text] [Related]
17. RhoA, RhoB and RhoC have different roles in cancer cell migration.
Ridley AJ
J Microsc; 2013 Sep; 251(3):242-9. PubMed ID: 23488932
[TBL] [Abstract][Full Text] [Related]
18. Involvement of local lamellipodia in endothelial barrier function.
Breslin JW; Zhang XE; Worthylake RA; Souza-Smith FM
PLoS One; 2015; 10(2):e0117970. PubMed ID: 25658915
[TBL] [Abstract][Full Text] [Related]
19. CSN5 inhibition triggers inflammatory signaling and Rho/ROCK-dependent loss of endothelial integrity.
Majolée J; Pronk MCA; Jim KK; van Bezu JSM; van der Sar AM; Hordijk PL; Kovačević I
Sci Rep; 2019 May; 9(1):8131. PubMed ID: 31148579
[TBL] [Abstract][Full Text] [Related]
20. The Cullin-3-Rbx1-KCTD10 complex controls endothelial barrier function via K63 ubiquitination of RhoB.
Kovačević I; Sakaue T; Majoleé J; Pronk MC; Maekawa M; Geerts D; Fernandez-Borja M; Higashiyama S; Hordijk PL
J Cell Biol; 2018 Mar; 217(3):1015-1032. PubMed ID: 29358211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]